Therefore, ANGPTL2 may serve as a biomarker and mediator of kidney inflammation and fibrosis during diabetes (Ishii et al., 2019)
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety
Given the large number of people who might benefit from these medications for weight loss, they could have a meaningful and long-term impact on the costs of health benefits
BMI is an imperfect measure, but its still one of the tools clinicians and insurers use to determine eligibility
Studies show GLP1RA for weight loss, compared to bupropion-naltrexone, are linked to higher risks of pancreatitis, gastroparesis, and bowel obstruction, but not biliary disease 70